Medication info
Laro Bon Plus Tablet

Laro Bon Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Raloxifene Hydrochloride›60mg / 1 tabletCholecalciferol Concentrate Powder›8mg / 1 tablet
Manufacturer / importer
LG Chem, Ltd.
Appearance
Yellow, round film-coated tablet
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201707354 · Approved 2017.09.29

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Take this medicine if you require raloxifene therapy and have an inadequate intake of vitamin D. Take 1 tablet orally once daily.

Ingredients

Manufacturer
LG Chem, Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women.

How to take

Adult dose

Take this medicine if you require raloxifene therapy and have an inadequate intake of vitamin D. Take 1 tablet orally once daily.

Precautions

This medication may increase the risk of blood clots, so caution is needed for patients with a history of thrombosis or those at high risk of thrombosis. This medication is primarily metabolized in the liver, so its use is not recommended for patients with poor liver function, and close observation is necessary if signs of liver dysfunction are present during treatment. The use of this medication has not been approved for premenopausal women, so it should not be taken. Caution is warranted when using this medication in postmenopausal women at high risk of cardiovascular disease as it may increase the risk of death from stroke. This medication should not be used for the prevention of cardiovascular diseases, and its combined use with other hormonal therapies is not recommended as safety has not been established. Women who are pregnant, might become pregnant, or are nursing should not take this medication due to potential harm to the fetus or newborn. Patients with a history of thrombosis, liver impairment, uterine bleeding, suspicion of endometrial cancer symptoms, those with prolonged immobilization, and patients with certain metabolic disorders should not take this medication. Patients with hypertriglyceridemia, renal impairment, kidney stones, and those taking certain medications should use caution and regularly monitor their condition under a doctor's guidance. Side effects such as vasodilation, leg cramps, cold symptoms, peripheral edema may occur during treatment; notify healthcare professionals if abnormal symptoms appear. This medication is used together with vitamin D supplements, and patients at high risk of vitamin D deficiency may need additional supplementation. Drug interactions may occur when taking with other medications, so inform healthcare professionals of any medications being taken. In case of overdose, symptoms such as dizziness, vomiting, and muscle cramps may occur; seek immediate medical attention for appropriate treatment. Safety and efficacy have not been established for children, and special caution is needed for elderly patients. This medication should be kept out of the reach of children, and transferring it to another container may compromise its quality, so care should be taken.

Side effects

Vasodilation (flushing), deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, superficial venous thrombophlebitis, leg cramps, cold symptoms, peripheral edema, decreased platelet count, elevated AST and ALT, cholelithiasis, thrombocytopenia, nausea, vomiting, abdominal pain, dyspepsia, increased blood pressure, migraine, headache, rash, breast symptoms (pain, swelling, tenderness), arterial thromboembolism, retinal vein occlusion, stroke, death related to deep venous thrombosis, facial flushing, vaginal bleeding, facial edema, heartburn, constipation, itching, fever, weakness, sweating, myalgia, insomnia, perineal pain, weight gain, arthritis, rheumatic-like symptoms, pain, fatigue, heaviness, chest discomfort, skin lesions, anxiety, weight loss, convulsions, dyspnea, visual disturbances, taste disturbances, mental symptoms, consciousness disorders, decreased appetite, increased thirst, arrhythmia, increased urinary urgency, kidney stones, renal calcification, calcification of outer bone tissue, myalgia, arthralgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is between 1°C and 30°C.

Appearance and packaging

Appearance

Yellow, round film-coated tablet

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.